David F. Horrobin - Concepedia

Author

David F. Horrobin

Also Known As

D F Horrobin, D HORROBIN, D Horrobin, D. F Horrobin, D. F. HORROBIN, D. F. Horrobin, D. Horrobin, D.F Horrobin, D.F. HORROBIN, D.F. HORROBIN,

703

Publications

20.6K

Citations

H-Index

294

Concepts

All Affiliations

Montreal Clinical Research Institute Université de Montréal

About

David F. Horrobin is an author at Montreal Clinical Research Institute specializing in medicine, pharmacology, and physiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Health Sciences	27	55	2.5K
2	Education	3	3	161
3	Humanities	3	3	181
4	Engineering	2	2	61
5	Business	1	1	172

David F. Horrobin

266

Publications

16.1K

Citations

H-Index

Page 1

	Year	Citations
A Dose-Ranging Study of the Effects of Ethyl-Eicosapentaenoate in Patients With Ongoing Depression Despite Apparently Adequate Treatment With Standard Drugs Malcolm Peet, David F. Horrobin Archives of General Psychiatry	2002	616
Depletion of Omega-3 Fatty Acid Levels in Red Blood Cell Membranes of Depressive Patients Malcolm Peet, Brendan Murphy, Janet Shay, Biological Psychiatry Metabolic SyndromeDepressive PatientsPsychiatryOmega-3 Fatty AcidLipid Nutrition	1998	581
The Philosophical Basis of Peer Review and the Suppression of Innovation David F. Horrobin JAMA	1990	416
A dose-ranging exploratory study of the effects of ethyl-eicosapentaenoate in patients with persistent schizophrenic symptoms Malcolm Peet, David F. Horrobin Journal of Psychiatric Research Psychoactive DrugPsychiatryPsychotic DisorderMedicineAddiction	2002	329
Differential Killing of Human Carcinoma Cells Supplemented With n-3 and n-6 Polyunsaturated Fatty Acids<xref ref-type="fn" rid="FN2">2</xref> M.E. Bégin, G. Ells, Undurti N. Das, JNCI Journal of the National Cancer Institute PathologyCell DeathCancer BiologyTumor BiologyFatty Acids	1986	292
A red cell membrane abnormality in a subgroup of schizophrenic patients: evidence for two diseases A.I.M. Glen, E.M.T. Glen, David F. Horrobin, Schizophrenia Research Schizophrenic PatientsNeuropsychologyPsychiatryPsychotic DisorderSchizophrenia	1994	252
Fatty acid levels in the brains of schizophrenics and normal controls David F. Horrobin, Mehar S. Manku, Harold Hillman, Biological Psychiatry Fatty Acid LevelsNeuropsychologyNormal ControlsPsychiatrySchizophrenia	1991	242
Essential polyunsaturated fatty acid and lipid peroxide levels in never-medicated and medicated schizophrenia patients Meena Arvindakshan, Sandhya L. Sitasawad, Vijay B Debsikdar, Biological Psychiatry PsychiatryPsychotropic MedicationMedicated Schizophrenia PatientsLipid Peroxide LevelsSchizophrenia	2002	231
Fatty acids in plasma and red cell membranes in normal humans M.S. Manku, David F. Horrobin, Y‐S. Huang Lipids	1983	224
Age-related changes in synaptic function: analysis of the effect of dietary supplementation with ω-3 fatty acids B. McGahon, Darren S.D. Martin, David F. Horrobin, Neuroscience Age-related ChangesNutritionSynaptic Plasticityω-3 Fatty AcidsAging	1999	216

Page 1